Hormonal Contraceptives Market | Need for Family Planning to Drive Growth
AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., and Merck and Co. Inc. are among the key vendors discussed in the research report
The Global Hormonal contraceptives market is likely to grow by $ 5.24 billion, accelerating at a CAGR of 5.30% till 2026. Several factors such as increase in unplanned pregnancies will drive market growth. Governments worldwide have been making efforts to tackle the issue of unplanned pregnancies, but their initiatives have been undermined by public healthcare cuts. Another key factor driving the global hormonal contraceptives market growth is the growing awareness about the importance of family planning in developing countries. Voluntary family planning has been widely adopted across the world through the efforts of the media and governments.
This research report lists all the growth drivers that are likely to boost market growth along with a detailed analysis of the market segments, trends and challenges that are likely to impact market growth. The goal of this research report is to furnish clients with insights that will help them leverage growth opportunities to implement business growth.
Request for our free sample report for more market insights: Download FREE Sample Report
Hormonal Contraceptives Market: Segments and Geographical Regions
- This report segments the market by method (oral contraceptives, implanted contraceptives, injected contraceptives, intrauterine, and others), and by Geography (North America, Asia, Europe, and ROW).
- 34% of the market growth will originate from North America during the forecast period.
- This research report will provide insights into the current market share of each segment along with growth projections for the next five years. Request our Free Sample Report
Hormonal Contraceptives Market: Vendor Analysis
- The market is fragmented due to the presence of several players.
- The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
- AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. are some of the major market participants.
- AbbVie Inc. for instance, offers hormonal contraceptives that include products such as pharmaceutical drugs Humira, Imbruvica, Venclexta, Zinbryta, Kaletra, Norvir, Mavyret, Skyrizi, and Rinvoq
Market Segmentation by Geography
-
- Hormonal Contraceptives Market Split by Geography
- North America
- Asia
- Europe
- ROW
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC - Market size and forecast 2020-2025
- MEA - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- South America - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- AbbVie Inc.
- Afaxys Pharma LLC
- Bayer AG
- HLL Lifecare Ltd.
- Johnson and Johnson Inc.
- Lupin Ltd.
- Merck and Co. Inc.
- Mylan NV
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Technavio also offers custom research reports with detailed insights assessing the market from a global as well as regional perspective. This customized report will help clients keep up with new product launches in direct & indirect or related markets. It will also provide insights on upcoming developments along with a pipeline analysis of vendor operations and the impact of government regulations. For more insights on this market: Download a Free Sample Report
The report provides insights into the following FAQs:
- What is the market CAGR?
The market will accelerate at a CAGR of 5.30%.
- What is the incremental growth of the market?
The market is expected to grow by $ 5.24 billion through 2022-2026.
- What is a key factor driving this market?
Increase in unplanned pregnancies will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Asia, Europe, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
34% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
- What are the market segments covered in this report?
The market is segmented by Geography (North America, Asia, Europe, and ROW)
